CapsoVision, Inc. (CV)
NASDAQ: CV · Real-Time Price · USD
4.290
+0.070 (1.66%)
Aug 7, 2025, 4:00 PM - Market closed
Verve Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Buy
Price Target
$5.00
Upside
+16.55%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Benchmark | Benchmark | Buy Initiates $5 | Buy | Initiates | $5 | +16.55% | Jul 28, 2025 |